CCOC(=O)c1ccc(CN(Cc2ccc(OC)cc2)S(=O)(=O)c2cccc(C(F)(F)F)c2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?